论文部分内容阅读
目的:探讨尽早进行溶栓治疗心肌梗死的临床意义。方法:选取105名心肌梗死患者进行尿激素酶溶栓治疗。将其平均分为A、B、C三组:对比观察溶栓时间不同的心肌梗死患者的疗效。结果:三组心肌梗死患者的冠脉再通率呈现A组>B组>C组,A组的冠脉再通率最高,B组次之,C组的冠脉再通率最低。三组相比,A组的冠脉再通率显著高于其他两组,比较差异具有统计学意义,(P<0.05)。此外,A组的死亡率也明显低于其他两组,比较差异具有统计学意义,(P<0.05)。并且,A组的CPK峰值时间、CK-MB峰值时间均明显短于另外两组,比较差异具有统计学意义,(P<0.05)。B组的CPK峰值时间、CK-MB峰值时间均明显短于C组,比较差异具有统计学意义,(P<0.05)。结论:提早对心肌梗死患者进行溶栓治疗,对疗效的提高以及患者预后的改善均具有重要意义。
Objective: To investigate the clinical significance of early thrombolytic therapy for myocardial infarction. Methods: 105 patients with myocardial infarction were enrolled in this study. The average is divided into A, B, C three groups: comparative observation of thrombolytic time in patients with different myocardial infarction curative effect. Results: The rate of coronary recanalization in the three groups of patients with myocardial infarction showed A group> B group> C group. A group had the highest rate of coronary recanalization, followed by B group and C group with the lowest recanalization rate. Compared with the three groups, the rate of coronary recanalization in group A was significantly higher than that in the other two groups, with statistical significance (P <0.05). In addition, the mortality of group A was also significantly lower than the other two groups, the difference was statistically significant (P <0.05). Moreover, the peak time of CPK and the peak time of CK-MB in group A were significantly shorter than the other two groups, with statistical significance (P <0.05). The CPK peak time and CK-MB peak time in group B were significantly shorter than those in group C, with statistical significance (P <0.05). Conclusion: Early thrombolysis in patients with myocardial infarction, the improvement of efficacy and prognosis of patients are of great significance.